+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Contract Manufacturing and Research Services Market Size, Share & Trends Analysis Report by Service (Manufacturing, Research), Region (North America, Europe, Asia-Pacific, Latin America) with Growth Forecasts, 2025-2030- Product Image
Pharmaceutical Contract Manufacturing and Research Services Market Size, Share & Trends Analysis Report by Service (Manufacturing, Research), Region (North America, Europe, Asia-Pacific, Latin America) with Growth Forecasts, 2025-2030- Product Image
New

Pharmaceutical Contract Manufacturing and Research Services Market Size, Share & Trends Analysis Report by Service (Manufacturing, Research), Region (North America, Europe, Asia-Pacific, Latin America) with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 4312535
Description Jump to:
The Pharmaceutical Contract Manufacturing and Research Services Market was valued at USD 263.37 billion in 2024, and is projected to reach USD 395.23 billion by 2030, rising at a CAGR of 6.90%. Pharmaceutical companies are increasingly leveraging CMOs and CDMOs to avoid substantial capital investments in infrastructure and navigate complex regulatory landscapes. This strategic move allows them to concentrate resources on core competencies like drug discovery and commercialization. The economies of scale achieved by specialized contract organizations further contribute to reduced production costs.

The escalating complexity of drug development, particularly in biologics, biosimilars, HPAPIs, and personalized medicine, necessitates the advanced capabilities and expertise readily available within contract service providers. These organizations often possess cutting-edge technologies such as continuous manufacturing and sophisticated handling systems, which prove vital for efficient and compliant production.

Global health trends, including the rising prevalence of chronic diseases and the demand for affordable generics and biosimilars following patent expirations, are also key growth drivers. The stringent and evolving regulatory environment, coupled with the imperative for faster market entry, incentivizes pharmaceutical companies to utilize the established expertise of CMOs and CDMOs. The strategic geographic shifts towards cost-competitive regions like Asia-Pacific and the emergence of integrated CRO-CDMO models offering comprehensive solutions underscore the dynamic growth of this market.

Pharmaceutical Contract Manufacturing And Research Services Market Report Highlights

  • Based on service, pharmaceutical contract manufacturing services dominated the market with over 60.0% of the total revenue share in 2024, driven by the need for scale and cost efficiency in producing generics, biosimilars, and vaccines.
  • Contract manufacturers offer essential capacity, flexibility, and regulatory support, facilitating growth in regions like Asia-Pacific.
  • Pharmaceutical contract research services are projected to witness the fastest CAGR of 7.0% over the forecast period.
  • Increasing R&D in complex areas and the demand for CROs' specialized expertise offer cost and time savings in global trials through advanced technologies and navigating regulatory complexities.
  • The Asia-Pacific pharmaceutical contract manufacturing and research services market dominated the global market with a revenue share of more than 40.0% in 2024, supported by increased outsourcing in developing economies like Singapore, China, and India, which have expanding manufacturing capabilities and significant CMO investments.
  • In November 2024, Lonza (Switzerland) announced a significant expansion of its bioconjugation capabilities in Visp. This investment includes adding two 1,200L manufacturing suites to meet increasing market demand.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service
1.2.2. Regional scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Service outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Pharmaceutical Contract Manufacturing And Research Services Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Pharmaceutical Contract Manufacturing And Research Services Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Pharmaceutical Contract Manufacturing And Research Services Market: Service Estimates & Trend Analysis
4.1. Service Segment Dashboard
4.2. Pharmaceutical Contract Manufacturing And Research Services Market: Service Movement Analysis
4.3. Global Pharmaceutical Contract Manufacturing And Research Services Market Size & Trend Analysis, by Service, 2018 to 2030 (USD Million)
4.4. Manufacturing
4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. API/Bulk Drugs
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Advanced Drug Delivery Formulations
4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.4. Packaging
4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5. Finished Dose Formulations
4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.2. Solid
4.4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.3. Liquid
4.4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.5.4. Semi-solid Formulations
4.4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Research
4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.2. Oncology
4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.3. Vaccines
4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.4. Inflammation & Immunology
4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.5. Cardiology
4.5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.6. Neuroscience
4.5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.5.7. Others
4.5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Pharmaceutical Contract Manufacturing And Research Services Market: Regional Estimates & Trend Analysis
5.1. Regional Market Dashboard
5.2. Regional Market Share Analysis, 2024 & 2030
5.3. Pharmaceutical contract manufacturing and research services market by Region: Key Takeaways
5.4. North America
5.4.1. U.S.
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Canada
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Mexico
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Europe
5.5.1. UK
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. Germany
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
5.5.3. France
5.5.3.1. Key country dynamics
5.5.3.2. Regulatory framework/ reimbursement structure
5.5.3.3. Competitive scenario
5.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
5.5.4. Italy
5.5.4.1. Key country dynamics
5.5.4.2. Regulatory framework/ reimbursement structure
5.5.4.3. Competitive scenario
5.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
5.5.5. Spain
5.5.5.1. Key country dynamics
5.5.5.2. Regulatory framework/ reimbursement structure
5.5.5.3. Competitive scenario
5.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
5.5.6. Denmark
5.5.6.1. Key country dynamics
5.5.6.2. Regulatory framework/ reimbursement structure
5.5.6.3. Competitive scenario
5.5.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
5.5.7. Sweden
5.5.7.1. Key country dynamics
5.5.7.2. Regulatory framework/ reimbursement structure
5.5.7.3. Competitive scenario
5.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
5.5.8. Norway
5.5.8.1. Key country dynamics
5.5.8.2. Regulatory framework/ reimbursement structure
5.5.8.3. Competitive scenario
5.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Asia Pacific
5.6.1. China
5.6.1.1. Key country dynamics
5.6.1.2. Regulatory framework/ reimbursement structure
5.6.1.3. Competitive scenario
5.6.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
5.6.2. Japan
5.6.2.1. Key country dynamics
5.6.2.2. Regulatory framework/ reimbursement structure
5.6.2.3. Competitive scenario
5.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
5.6.3. India
5.6.3.1. Key country dynamics
5.6.3.2. Regulatory framework/ reimbursement structure
5.6.3.3. Competitive scenario
5.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
5.6.4. Australia
5.6.4.1. Key country dynamics
5.6.4.2. Regulatory framework/ reimbursement structure
5.6.4.3. Competitive scenario
5.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
5.6.5. South Korea
5.6.5.1. Key country dynamics
5.6.5.2. Regulatory framework/ reimbursement structure
5.6.5.3. Competitive scenario
5.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
5.6.6. Thailand
5.6.6.1. Key country dynamics
5.6.6.2. Regulatory framework/ reimbursement structure
5.6.6.3. Competitive scenario
5.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Latin America
5.7.1. Brazil
5.7.1.1. Key country dynamics
5.7.1.2. Regulatory framework/ reimbursement structure
5.7.1.3. Competitive scenario
5.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
5.7.2. Argentina
5.7.2.1. Key country dynamics
5.7.2.2. Regulatory framework/ reimbursement structure
5.7.2.3. Competitive scenario
5.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
5.8. MEA
5.8.1. South Africa
5.8.1.1. Key country dynamics
5.8.1.2. Regulatory framework/ reimbursement structure
5.8.1.3. Competitive scenario
5.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
5.8.2. Saudi Arabia
5.8.2.1. Key country dynamics
5.8.2.2. Regulatory framework/ reimbursement structure
5.8.2.3. Competitive scenario
5.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
5.8.3. UAE
5.8.3.1. Key country dynamics
5.8.3.2. Regulatory framework/ reimbursement structure
5.8.3.3. Competitive scenario
5.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
5.8.4. Kuwait
5.8.4.1. Key country dynamics
5.8.4.2. Regulatory framework/ reimbursement structure
5.8.4.3. Competitive scenario
5.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Vendor Landscape
6.3.1. Key company heat map analysis, 2024
6.4. Company Profiles
6.4.1. Catalent, Inc (Novo Holdings A/S)
6.4.1.1. Company overview
6.4.1.2. Financial performance
6.4.1.3. Product benchmarking
6.4.1.4. Strategic initiatives
6.4.2. PPD (Thermo Fisher Scientific Inc.)
6.4.2.1. Company overview
6.4.2.2. Financial performance
6.4.2.3. Product benchmarking
6.4.2.4. Strategic initiatives
6.4.3. AbbVie Inc.
6.4.3.1. Company overview
6.4.3.2. Financial performance
6.4.3.3. Product benchmarking
6.4.3.4. Strategic initiatives
6.4.4. Advent International, L.P.
6.4.4.1. Company overview
6.4.4.2. Financial performance
6.4.4.3. Product benchmarking
6.4.4.4. Strategic initiatives
6.4.5. Grifols
6.4.5.1. Company overview
6.4.5.2. Financial performance
6.4.5.3. Product benchmarking
6.4.5.4. Strategic initiatives
6.4.6. Dalton Pharma Services
6.4.6.1. Company overview
6.4.6.2. Financial performance
6.4.6.3. Product benchmarking
6.4.6.4. Strategic initiatives
6.4.7. Boehringer Ingelheim International GmbH
6.4.7.1. Company overview
6.4.7.2. Financial performance
6.4.7.3. Product benchmarking
6.4.7.4. Strategic initiatives
6.4.8. Lonza
6.4.8.1. Company overview
6.4.8.2. Financial performance
6.4.8.3. Product benchmarking
6.4.8.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 Global pharmaceutical contract manufacturing and research services market, by region, 2018-2030 (USD Million)
Table 3 Global pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 4 North America pharmaceutical contract manufacturing and research services market, by country, 2018-2030 (USD Million)
Table 5 North America pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 6 U.S. pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 7 Canada pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 8 Mexico pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 9 Europe pharmaceutical contract manufacturing and research services market, by country, 2018-2030 (USD Million)
Table 10 Europe pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 11 UK pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 12 Germany pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 13 France pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 14 Italy pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 15 Spain pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 16 Denmark pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 17 Sweden pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 18 Norway pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 19 Asia Pacific pharmaceutical contract manufacturing and research services market, by country, 2018-2030 (USD Million)
Table 20 Asia Pacific pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 21 China pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 22 Japan pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 23 India pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 24 Australia pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 25 South Korea pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 26 Thailand pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 27 Latin America pharmaceutical contract manufacturing and research services market, by country, 2018-2030 (USD Million)
Table 28 Latin America pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 29 Brazil pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 30 Argentina pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 31 MEA pharmaceutical contract manufacturing and research services market, by region, 2018-2030 (USD Million)
Table 32 MEA pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 33 South Africa pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 34 Saudi Arabia pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 35 UAE pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
Table 36 Kuwait pharmaceutical contract manufacturing and research services market, by service, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Primary interviews
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 QFD modeling for market share assessment
Figure 8 Market formulation & validation
Figure 9 Pharmaceutical contract manufacturing and research services market: market outlook
Figure 10 Pharmaceutical contract manufacturing and research services competitive insights
Figure 11 Parent market outlook
Figure 12 Related/ancillary market outlook
Figure 13 Penetration and growth prospect mapping
Figure 14 Industry value chain analysis
Figure 15 Pharmaceutical contract manufacturing and research services market driver impact
Figure 16 Pharmaceutical contract manufacturing and research services market restraint impact
Figure 17 Pharmaceutical contract manufacturing and research services market strategic initiatives analysis
Figure 18 Pharmaceutical contract manufacturing and research services market: Service movement analysis
Figure 19 Pharmaceutical contract manufacturing and research services market: Service outlook and key takeaways
Figure 20 Manufacturing estimates and forecast, 2018-2030
Figure 21 API/bulk drugs estimates and forecast, 2018-2030
Figure 22 Advanced drug delivery formulations estimates and forecast, 2018-2030
Figure 23 Packaging estimates and forecast, 2018-2030
Figure 24 Finished dose formulations estimates and forecast, 2018-2030
Figure 25 Solid estimates and forecast, 2018-2030
Figure 26 Liquid estimates and forecast, 2018-2030
Figure 27 Semi-solid formulations estimates and forecast, 2018-2030
Figure 28 Research estimates and forecast, 2018-2030
Figure 29 Oncology estimates and forecast, 2018-2030
Figure 30 Vaccines estimates and forecast, 2018-2030
Figure 31 Inflammation & immunology estimates and forecast, 2018-2030
Figure 32 Cardiology estimates and forecast, 2018-2030
Figure 33 Neuroscience estimates and forecast, 2018-2030
Figure 34 Others estimates and forecast, 2018-2030
Figure 35 Global pharmaceutical contract manufacturing and research services market: Regional movement analysis
Figure 36 Global pharmaceutical contract manufacturing and research services market: Regional outlook and key takeaways
Figure 37 North America market estimates and forecasts, 2018-2030
Figure 38 U.S. market estimates and forecasts, 2018-2030
Figure 39 Canada market estimates and forecasts, 2018-2030
Figure 40 Mexico market estimates and forecasts, 2018-2030
Figure 41 Europe market estimates and forecasts, 2018-2030
Figure 42 UK market estimates and forecasts, 2018-2030
Figure 43 Germany market estimates and forecasts, 2018-2030
Figure 44 France market estimates and forecasts, 2018-2030
Figure 45 Italy market estimates and forecasts, 2018-2030
Figure 46 Spain market estimates and forecasts, 2018-2030
Figure 47 Denmark market estimates and forecasts, 2018-2030
Figure 48 Sweden market estimates and forecasts, 2018-2030
Figure 49 Norway market estimates and forecasts, 2018-2030
Figure 50 Asia Pacific market estimates and forecasts, 2018-2030
Figure 51 China market estimates and forecasts, 2018-2030
Figure 52 Japan market estimates and forecasts, 2018-2030
Figure 53 India market estimates and forecasts, 2018-2030
Figure 54 Australia market estimates and forecasts, 2018-2030
Figure 55 South Korea market estimates and forecasts, 2018-2030
Figure 56 Thailand market estimates and forecasts, 2018-2030
Figure 57 Latin America market estimates and forecasts, 2018-2030
Figure 58 Brazil market estimates and forecasts, 2018-2030
Figure 59 Argentina market estimates and forecasts, 2018-2030
Figure 60 Middle East and Africa market estimates and forecasts, 2018-2030
Figure 61 South Africa market estimates and forecasts, 2018-2030
Figure 62 Saudi Arabia market estimates and forecasts, 2018-2030
Figure 63 UAE market estimates and forecasts, 2018-2030
Figure 64 Kuwait market estimates and forecasts, 2018-2030

Companies Mentioned

The major companies featured in this Pharmaceutical Contract Manufacturing and Research Services market report include:
  • Catalent, Inc (Novo Holdings A/S)
  • PPD (Thermo Fisher Scientific Inc.)
  • AbbVie Inc.
  • Advent International, L.P.
  • Grifols
  • Dalton Pharma Services
  • Boehringer Ingelheim International GmbH
  • Lonza

Table Information

Report AttributeDetails
No. of Pages100
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 263.37 Billion
Forecasted Market Value ( USD ) by 2030 $ 395.23 Billion
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Small Molecule, Biologics), Drug, Service, Scale of Operation, Workflow, Application, End Use, Company, and Region with Growth Forecasts, 2025-2030 - Product Image

Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Small Molecule, Biologics), Drug, Service, Scale of Operation, Workflow, Application, End Use, Company, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Generic Pharmaceuticals Contract Manufacturing Market Size, Share & Trends Analysis Report By Drug Type (Branded, Unbranded), By Product (API, Drug Product), By Route Of Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Generic Pharmaceuticals Contract Manufacturing Market Size, Share & Trends Analysis Report By Drug Type (Branded, Unbranded), By Product (API, Drug Product), By Route Of Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Pharmaceutical Contract Manufacturing & Research Services Market by Service Type, End-User - Global Forecast to 2030 - Product Image

Pharmaceutical Contract Manufacturing & Research Services Market by Service Type, End-User - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Fill-finish Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Product Type, Automation, Scale of Operation, End-Users - Global Forecast to 2030 - Product Image

Fill-finish Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Product Type, Automation, Scale of Operation, End-Users - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Manufactured, Type of API, API Potency, Type of FDF, Dosage Form, Type of Packaging Offered, Scale of Operation, End Users and Key Geographical Regions - Product Image

Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Product Manufactured, Type of API, API Potency, Type of FDF, Dosage Form, Type of Packaging Offered, Scale of Operation, End Users and Key Geographical Regions

  • Report
  • 545 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.